BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19196813)

  • 1. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
    Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA
    Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
    Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA
    Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.
    Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K
    Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.
    Stockley RA; Parr DG; Piitulainen E; Stolk J; Stoel BC; Dirksen A
    Respir Res; 2010 Oct; 11(1):136. PubMed ID: 20920370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
    Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.
    Holme J; Stockley RA
    Chest; 2009 Nov; 136(5):1284-1290. PubMed ID: 19892672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous alpha-1 antitrypsin augmentation therapy: systematic review.
    Gøtzsche PC; Johansen HK
    Dan Med Bull; 2010 Sep; 57(9):A4175. PubMed ID: 20816015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
    Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency.
    Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC
    Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.
    Parr DG; Stoel BC; Stolk J; Stockley RA
    Thorax; 2006 Jun; 61(6):485-90. PubMed ID: 16537666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of regional progression of pulmonary emphysema with CT densitometry.
    Bakker ME; Putter H; Stolk J; Shaker SB; Piitulainen E; Russi EW; Stoel BC
    Chest; 2008 Nov; 134(5):931-937. PubMed ID: 18625668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antitrypsin augmentation therapy.
    Pierce JA
    Chest; 1997 Oct; 112(4):872-4. PubMed ID: 9377947
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha1-antitrypsin deficiency. 7: Computed tomographic imaging in alpha1-antitrypsin deficiency.
    Shaker SB; Stavngaard T; Stolk J; Stoel B; Dirksen A
    Thorax; 2004 Nov; 59(11):986-91. PubMed ID: 15516477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?
    Schwaiblmair M; Vogelmeier C
    Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of calibration on densitometric studies of emphysema progression using computed tomography.
    Parr DG; Stoel BC; Stolk J; Nightingale PG; Stockley RA
    Am J Respir Crit Care Med; 2004 Oct; 170(8):883-90. PubMed ID: 15271692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.
    Lieberman J
    Chest; 2000 Nov; 118(5):1480-5. PubMed ID: 11083705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.